1
|
Maier P, Morath O, Barsch F, Krumnau O, Steinmann D, Deibert P. A Comparison of the Impact of COVID-19-Related Restrictions on Physical Activity Among Public Employees. J Occup Environ Med 2023; 65:e587-e592. [PMID: 37311075 DOI: 10.1097/jom.0000000000002906] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
OBJECTIVES This article compares the impact of COVID-19-related restrictions on the level of physical activity, performed by public servants, in April and November 2020. METHODS The survey examined the amount (in minutes per week) and the energy expenditure (in metabolic equivalent of task in minutes per week [METmin/week]) of physical activity for both before and during contact restrictions in April and November 2020, respectively. RESULTS Especially for sports activity difference was determined by the medians before (April/November: median [Mdn] = 180.0 min/wk) and during (April: Mdn = 130 minutes, November: Mdn = 60 min/wk) restrictions ( P < 0.05).Also for energy consumption (METmin/wk), the medians before and during the contact restrictions declined for both periods. CONCLUSIONS Measures against the coronavirus have led to a reduction in activity levels among public employees, regardless of their work environment. The decrease in participation in sport activities seemed to be even more noticeable within the second restriction period.
Collapse
Affiliation(s)
- Philipp Maier
- From the Department of Medicine, Faculty of Medicince, Medical Center University of Freiburg, Institute for Exercise and Occupational Medicine (P.M., O.M., F.B., O.K., P.D.), University of Freiburg, Freiburg im Breisgau, Germany; and Occupational Medical Service, Freiburg University Medical Center (D.S.), Faculty of Medicine, Albert-Ludwigs-University of Freiburg, Freiburg, Germany
| | | | | | | | | | | |
Collapse
|
2
|
Maier P, Barsch F, Morath O, Krumnau O, Prettin S, Steinmann D, Deibert P. [Influence of the contact restrictions against SARS-CoV-2 on physical activity among public sector employees.]. ZENTRALBLATT FUR ARBEITSMEDIZIN, ARBEITSSCHUTZ UND ERGONOMIE 2023; 73:32-38. [PMID: 36589472 PMCID: PMC9788866 DOI: 10.1007/s40664-022-00487-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 07/28/2022] [Accepted: 11/10/2022] [Indexed: 12/25/2022]
Abstract
Objective Preliminary results from activity surveys conducted in spring 2020 suggest that athletic activity may have decreased within the contact restrictions against the spread of coronavirus. The coronavirus pandemic poses many challenges to the workforce in the healthcare system. Therefore, this study investigated whether the measures to limit the pandemic have an influence on the activity behavior of employees in the public sector. Method A retrospective cross-sectional survey was conducted to collate the activity behavior among employees of three institutions in the public sector before and during the measures against the coronavirus in April 2020. An online version of the Freiburg Activity Questionnaire was used. Using Wilcoxon tests on connected samples with a significance level of p < 0.05, the activity behavior was examined for differences before compared to during the contact restrictions in min/week and MET-min./week. Results A total of 1797 public sector employees in Freiburg (36.0% male, 63.9% female, and 0.1% diverse) participated in the survey. For sports activity, a relevant difference (p < 0.05) was measured in the medians (Mdn) of activities per week before (Mdn = 180 min) and during (Mdn = 120 min) the relevant contact restrictions. Similarly, for energy expenditure through exercise, the median value within the contact restrictions decreased from Mdn = 1022 MET-min/week to Mdn = 750 MET-min./week. Conclusion Measures to limit the spread of the coronavirus have led to a reduction in activity levels among public sector employees. In particular, fewer employees engaged in sports. This could be related to the closure of fitness studios as these activities were particularly reduced. Decreased physical activity can lead to unfavorable individual risk profiles, which must be compensated for in the future.
Collapse
Affiliation(s)
- Philipp Maier
- Institut für Bewegungs- und Arbeitsmedizin, Medizinische Fakultät, Universitätsklinikum Freiburg, Hugstetter Str. 55, 79106 Freiburg, Deutschland
| | - Friedrich Barsch
- Institut für Bewegungs- und Arbeitsmedizin, Medizinische Fakultät, Universitätsklinikum Freiburg, Hugstetter Str. 55, 79106 Freiburg, Deutschland
| | - Oliver Morath
- Institut für Bewegungs- und Arbeitsmedizin, Medizinische Fakultät, Universitätsklinikum Freiburg, Hugstetter Str. 55, 79106 Freiburg, Deutschland
| | - Oliver Krumnau
- Institut für Bewegungs- und Arbeitsmedizin, Medizinische Fakultät, Universitätsklinikum Freiburg, Hugstetter Str. 55, 79106 Freiburg, Deutschland
| | - Stephan Prettin
- Institut für Bewegungs- und Arbeitsmedizin, Medizinische Fakultät, Universitätsklinikum Freiburg, Hugstetter Str. 55, 79106 Freiburg, Deutschland
| | - Daniel Steinmann
- Betriebsärztlicher Dienst, Universitätsklinikum Freiburg, Freiburg, Deutschland
| | - Peter Deibert
- Institut für Bewegungs- und Arbeitsmedizin, Medizinische Fakultät, Universitätsklinikum Freiburg, Hugstetter Str. 55, 79106 Freiburg, Deutschland
| |
Collapse
|
3
|
Nagata JM, Vittinghoff E, Pettee Gabriel K, Garber AK, Moran AE, Rana JS, Reis JP, Sidney S, Bibbins-Domingo K. Moderate-to-vigorous intensity physical activity from young adulthood to middle age and metabolic disease: a 30-year population-based cohort study. Br J Sports Med 2022; 56:847-853. [PMID: 34521685 PMCID: PMC9017156 DOI: 10.1136/bjsports-2021-104231] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/28/2021] [Indexed: 11/03/2022]
Abstract
OBJECTIVES To determine the association between moderate-to-vigorous intensity physical activity (MVPA) trajectories (course over age and time) through the adult life course and onset of metabolic disease (diabetes and dyslipidaemia). METHODS We analysed prospective community-based cohort data of 5115 participants in the Coronary Artery Risk Development in Young Adults study, who were black and white men and women aged 18-30 years at baseline (1985-1986) at four urban sites, collected through 30 years of follow-up. Individualised MVPA trajectories were developed for each participant using linear mixed models. RESULTS Lower estimated MVPA score at age 18 was associated with a 12% (95% CI 6% to 18%) higher odds of incident diabetes, a 4% (95% CI 1% to 7%) higher odds of incident low high-density lipoprotein (HDL) and a 6% (95% CI 2% to 11%) higher odds of incident high triglycerides. Each additional annual 1-unit reduction in the MVPA score was associated with a 6% (95% CI 4% to 9%) higher annual odds of diabetes incidence and a 4% (95% CI 2% to 6%) higher annual odds of high triglyceride incidence. Analysing various MVPA trajectory groups, participants who were in the most active group at age 18 (over 300 min/week), but with sharp declines in midlife, had higher odds of high low-density lipoprotein and low HDL incidence, compared with those in the most active group at age 18 with subsequent gains. CONCLUSION Given recent trends in declining MVPA across the life course and associated metabolic disease risk, young adulthood is an important time period for interventions to increase and begin the maintenance of MVPA.
Collapse
Affiliation(s)
- Jason M Nagata
- Division of Adolescent and Young Adult Medicine, Department of Pediatrics, University of California San Francisco, San Francisco, California, USA
| | - Eric Vittinghoff
- Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA
| | - Kelley Pettee Gabriel
- Department of Epidemiology, The University of Alabama at Birmingham, Birmingham, Alabama, USA
| | - Andrea K Garber
- Division of Adolescent and Young Adult Medicine, Department of Pediatrics, University of California San Francisco, San Francisco, California, USA
| | - Andrew E Moran
- Division of General Medicine, Columbia University, New York, New York, USA
| | - Jamal S Rana
- Division of Cardiology, Kaiser Permanente Northern California, Oakland, California, USA
- Division of Research, Kaiser Permanente Northern California, Oakland, California, USA
| | - Jared P Reis
- Division of Cardiovascular Sciences, National Heart Lung and Blood Institute, Bethesda, Maryland, USA
| | - Stephen Sidney
- Division of Research, Kaiser Permanente Northern California, Oakland, California, USA
| | - Kirsten Bibbins-Domingo
- Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA
| |
Collapse
|
4
|
Khalaf RA, NasrAllah A, Jarrar W, Sabbah DA. Cholesteryl ester transfer protein inhibitory oxoacetamido-benzamide derivatives: Glide docking, pharmacophore mapping, and synthesis. BRAZ J PHARM SCI 2022. [DOI: 10.1590/s2175-97902022e20028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
|
5
|
Chen J, Ye C, Yang Z, Wang T, Xu B, Li P, Zhang S, Xue X. Study on the Effect of Macrophages on Vascular Endothelium in Mice With Different TCM Syndromes of Dyslipidemia and its Biological Basis Based on RNA-Seq Technology. Front Pharmacol 2021; 12:665635. [PMID: 34512320 PMCID: PMC8427158 DOI: 10.3389/fphar.2021.665635] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2021] [Accepted: 08/12/2021] [Indexed: 12/12/2022] Open
Abstract
Background: “Treating the same disease with different methods” is a Traditional Chinese medicine (TCM) therapeutic concept suggesting that, while patients may be diagnosed with the same disease, they may also have different syndromes that require distinct drug administrations. Objective: This study aimed to identify the differentially expressed genes and related biological processes in dyslipidemia in relation to phlegm–dampness retention (PDR) syndrome and spleen and kidney Yang deficiency (SKYD) syndrome using transcriptomic analysis. Methods: Ten ApoE−/− mice were used for the establishment of dyslipidemic disease–syndrome models via multifactor-hybrid modeling, with five in the PDR group and five in the SKYD group. Additionally, five C57BL/6J mice were employed as a normal control group. Test model-quality aortic endothelial macrophages in mice were screened using flow cytometry. Transcriptomic analysis was performed for macrophages using RNA-Seq. Results: A quality assessment of the disease–syndrome model showed that levels of lipids significantly increased in the PDR and SKYD groups, compared to the normal control group, p < 0.05. Applying, in addition, hematoxylin and eosin staining of aorta, the disease model was also successfully established. A quality assessment of the syndrome models showed that mice in the PDR group presented with typical manifestations of PDR syndrome, and mice in the SKYD group had related manifestations of SKYD syndrome, indicating that the syndrome models were successfully constructed as well. After comparing the differentially expressed gene expressions in macrophages of the dyslipidemic mice with different syndromes, 4,142 genes were identified with statistical significance, p < 0.05. Gene ontology analysis for the differentially expressed genes showed that the biological process of difference between the PDR group and the SKYD group included both adverse and protective processes. Conclusion: The differentially expressed genes between PDR syndrome and SKYD syndrome indicate different biological mechanisms between the onsets of the two syndromes. They have distinctive biological processes, including adverse and protective processes that correspond to the invasion of pathogenic factors into the body and the fight of healthy Qi against pathogenic factors, respectively, according to TCM theory. Our results provide biological evidence for the TCM principle of “treating the same disease with different treatments.”
Collapse
Affiliation(s)
- Jing Chen
- Preventive Treatment of Disease Department, The Third Affiliated Hospital, Beijing University of Chinese Medicine, Beijing, China
| | - Chao Ye
- Orthopedics Department, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China
| | - Zheng Yang
- School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China
| | - Tieshan Wang
- Beijing Research Institute of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China
| | - Bing Xu
- Traditional Chinese Medicine Department, Tibetology Research Center of Beijing Tibetan Medicine Hospital, Beijing, China
| | - Pengyang Li
- Orthopedics Department, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China
| | - Shan Zhang
- School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China
| | - Xiaolin Xue
- School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China
| |
Collapse
|
6
|
Murthy VL, Xia R, Baldridge AS, Carnethon MR, Sidney S, Bouchard C, Sarzynski MA, Lima JAC, Lewis GD, Shah SJ, Fornage M, Shah RV. Polygenic Risk, Fitness, and Obesity in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. JAMA Cardiol 2021; 5:40-48. [PMID: 31913407 DOI: 10.1001/jamacardio.2019.5220] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
Importance Obesity is a major determinant of disease burden worldwide. Polygenic risk scores (PRSs) have been posited as key predictors of obesity. How a PRS can be translated to the clinical encounter (especially in the context of fitness, activity, and parental history of overweight) remains unclear. Objective To quantify the relative importance of a PRS, fitness, activity, parental history of overweight, and body mass index (BMI) (calculated as weight in kilograms divided by height in meters squared) in young adulthood on BMI trends over 25 years. Design, Setting, and Participants This population-based prospective cohort study at 4 US centers included white individuals and black individuals with assessments of polygenic risk of obesity, fitness, activity, and BMI in young adulthood (in their 20s) and up to 25 years of follow-up. Data collected between March 1985 and August 2011 were analyzed from April 25, 2019, to September 29, 2019. Main Outcomes and Measures Body mass index at the initial visit and 25 years later. Results This study evaluated an obesity PRS from a recently reported study of 1608 white individuals (848 women [52.7%]) and 909 black individuals (548 women [60.3%]) across the United States. At baseline (year 0), mean (SD) overall BMI was 24.2 (4.5), which increased to 29.6 (6.9) at year 25. Among white individuals, the PRS (combined with age, sex, self-reported parental history of overweight, and principal components of ancestry) explained 11.9% (at year 0) and 13.6% (at year 25) of variation in BMI. Although the addition of fitness increased the explanatory capability of the model (24.0% variance at baseline and up to 18.1% variance in BMI at year 25), baseline BMI in young adulthood was the strongest factor, explaining 52.3% of BMI in midlife in combination with age, sex, and self-reported parental history of overweight. Accordingly, models that included baseline BMI (especially BMI surveillance over time) were better in predicting BMI at year 25 compared with the PRS. In fully adjusted models, the effect sizes for fitness and the PRS on BMI were comparable in opposing directions. The added explanatory capacity of the PRS among black individuals was lower than among white individuals. Among white individuals, addition of baseline BMI and surveillance of BMI over time was associated with improved precision of predicted BMI at year 25 (mean error in predicted BMI 0 kg/m2 [95% CI, -11.4 to 11.4] to 0 kg/m2 [95% CI, -8.5 to 8.5] for baseline BMI and mean error 0 kg/m2 [95% CI, -5.3 to 5.3] for BMI surveillance). Conclusions and Relevance Cardiorespiratory fitness in young adulthood and a PRS are modestly associated with midlife BMI, although future BMI is associated with BMI in young adulthood. Fitness has a comparable association with future BMI as does the PRS. Caution should be exercised in the widespread use of polygenic risk for obesity prevention in adults, and close clinical surveillance and fitness may have prime roles in limiting the adverse consequences of elevated BMI on health.
Collapse
Affiliation(s)
- Venkatesh L Murthy
- Division of Cardiovascular Medicine, Department of Medicine, University of Michigan, Ann Arbor.,Frankel Cardiovascular Center, University of Michigan, Ann Arbor
| | - Rui Xia
- Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston
| | - Abigail S Baldridge
- Department of Preventative Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
| | | | - Stephen Sidney
- Kaiser Permanente Northern California Division of Research, Oakland
| | - Claude Bouchard
- Human Genomics Laboratory, Pennington Biomedical Research Center, Baton Rouge, Louisiana
| | - Mark A Sarzynski
- Department of Exercise Science, University of South Carolina, Columbia
| | - João A C Lima
- Department of Medicine, The Johns Hopkins School of Medicine, Baltimore, Maryland
| | - Gregory D Lewis
- Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston
| | - Sanjiv J Shah
- Department of Preventative Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.,Division of Cardiology, Department of Medicine, Northwestern University, Chicago, Illinois.,Associate Editor
| | - Myriam Fornage
- Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston
| | - Ravi V Shah
- Cardiology Division, Department of Medicine, Massachusetts General Hospital, Boston
| |
Collapse
|
7
|
Li W, Chen C, Chen M, Zhang X, Ji Q, Wang Y, Zheng Q, Tan S, Gao X, Lu Y. Salted and Unsalted Zhàcài (Brassica juncea var. tumida) Alleviated High-Fat Diet-Induced Dyslipidemia by Regulating Gut Microbiota: A Multiomics Study. Mol Nutr Food Res 2020; 64:e2000798. [PMID: 33098239 DOI: 10.1002/mnfr.202000798] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2020] [Revised: 09/23/2020] [Indexed: 12/15/2022]
Abstract
SCOPE Zhàcài (ZC), a salting-processed Brassica juncea var. tumida vegetable, is widely consumed as a pickle, but little is known about the health benefits of both salted and unsalted ZC as a whole food. METHODS AND RESULTS The preventive effects of salted and unsalted ZC against dyslipidemia are assessed in high-fat (HF) diet-fed mice. HF intake for 12 continuous weeks cause dyslipidemia in mice, as evidenced by the elevations in serum total triglyceride, total cholesterol, and low-density lipoprotein cholesterol levels by 30%, 66%, and 117%, respectively. Metabolomics analysis and the 16S rRNA genes sequencing suggest that dietary administration of salted and unsalted ZC (2.5% w/w) alleviates HF-induced dyslipidemia, metabolic disorders of short-chain fatty acids, and disturbance of intestinal flora in mice. These positive effects of unsalted ZC are stronger than those of salted ZC. Moreover, fecal bacteria transplantation confirms the antidyslipidemia of ZC. CONCLUSION These results suggest that consumption of ZC may prevent HF-induced dyslipidemia by regulating gut microbiota.
Collapse
Affiliation(s)
- Wenfeng Li
- School of Life Science and Biotechnology, Yangtze Normal University, Chongqing, 408100, China
| | - Chunlian Chen
- School of Life Science and Biotechnology, Yangtze Normal University, Chongqing, 408100, China
| | - Mengting Chen
- School of Life Science and Biotechnology, Yangtze Normal University, Chongqing, 408100, China
| | - Xiangyang Zhang
- School of Life Science and Biotechnology, Yangtze Normal University, Chongqing, 408100, China
| | - Qin Ji
- School of Life Science and Biotechnology, Yangtze Normal University, Chongqing, 408100, China
| | - Yu Wang
- School of Life Science and Biotechnology, Yangtze Normal University, Chongqing, 408100, China
| | - Qiaoran Zheng
- School of Life Science and Biotechnology, Yangtze Normal University, Chongqing, 408100, China
| | - Si Tan
- School of Life Science and Biotechnology, Yangtze Normal University, Chongqing, 408100, China
| | - Xiaoxv Gao
- School of Life Science and Biotechnology, Yangtze Normal University, Chongqing, 408100, China
| | - Yalong Lu
- College of Food Engineering and Nutritional Science, Shaanxi Normal University, Xi'an, 710062, China
| |
Collapse
|
8
|
|
9
|
Barzegar-Amini M, Ghazizadeh H, Seyedi SMR, Sadeghnia HR, Mohammadi A, Hassanzade-Daloee M, Barati E, Kharazmi-Khorassani S, Kharazmi-Khorassani J, Mohammadi-Bajgiran M, Tavallaie S, Ferns GA, Mouhebati M, Ebrahimi M, Tayefi M, Ghayour-Mobarhan M. Serum vitamin E as a significant prognostic factor in patients with dyslipidemia disorders. Diabetes Metab Syndr 2019; 13:666-671. [PMID: 30641786 DOI: 10.1016/j.dsx.2018.11.034] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/10/2018] [Accepted: 11/11/2018] [Indexed: 12/13/2022]
Abstract
OBJECTIVES Obesity and overweight are among the main causes of cardiovascular disease (CVD) mortality. Dyslipidemia, fatty liver index, is strongly related to CVD. Vitamin E as an antioxidant protects the hepatic cells against oxidative stress and prevents fatty liver disease. The aim of the current study is to evaluate the relationship between anthropometric parameters and fasted lipid profile with serum vitamin E levels. STUDY DESIGN A randomized trial was designed based on data from the Mashhad stroke and heart atherosclerotic disorders (MASHAD: 2010-2020). METHODS 363 CVD subjects (173 males and 190 females) was selected at random, among 9704 subjects in three regions of Mashhad, northeast of Iran to investigate the specific correlations among their serum vitamin E, lipid profile (TG, HDL-C, LDL-C and TC), and anthropometric features (height, weight, BMI, hip and waist circumferences. RESULT The results indicated the significant relationships between vitamin E, and fasting serum lipid profile in subjects. Serum vitamin E was negatively correlated to TC, TG, and LDL-C and positively related to HDL-C. Also, statistically negative correlations were found between vitamin E and anthropometric parameters (weight, waist and hip circumference, middle Arm, and Systolic Blood Pressure). Moreover, vitamin E ratios such as vitamin E/(TC + TG) and vitamin E/TC values as standardized vitamin E, had significant negative correlation with BMI, the whole of anthropometric parameters, and dyslipidemia risk factors including TC, TG and LDL-C. CONCLUSION We found that vitamin E profile was significantly lower in the dyslipidemia subjects. It is generally suggested that vitamin E monitoring might be used as a useful prognostic and therapeutic agent in dyslipidemia disorder.
Collapse
Affiliation(s)
- Maral Barzegar-Amini
- Cardiovascular Division, Vascular Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Hamideh Ghazizadeh
- Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | | | - Hamid Reza Sadeghnia
- Department of Pharmacology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Akram Mohammadi
- Department of Modern Sciences and Technologies, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Mahdi Hassanzade-Daloee
- Cardiovascular Division, Vascular Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Elham Barati
- Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Sara Kharazmi-Khorassani
- Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Biology, Mashad Branch, Islamic Azad University, Iran
| | - Jasmin Kharazmi-Khorassani
- Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Chemistry, Mashad Branch, Ferdowsi University, Iran
| | | | - Shima Tavallaie
- Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Gordon A Ferns
- Brighton & Sussex Medical School, Division of Medical Education, Falmer, Brighton, Sussex, BN1 9PH, UK
| | - Mohsen Mouhebati
- Cardiovascular Division, Vascular Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Cardiovascular Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Mahmoud Ebrahimi
- Cardiovascular Division, Vascular Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Cardiovascular Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Maryam Tayefi
- Clinical Research Unit, Mashhad University of Medical Sciences, Mashhad, Iran.
| | - Majid Ghayour-Mobarhan
- Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Modern Sciences and Technologies, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
| |
Collapse
|
10
|
Koba S. Physical Fitness and Development of High Non-High-Density Lipoprotein Cholesterol. J Atheroscler Thromb 2018; 25:1185-1187. [PMID: 30369545 PMCID: PMC6249365 DOI: 10.5551/jat.ed105] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
Affiliation(s)
- Shinji Koba
- Division of Cardiology, Department of Medicine, Showa University School of Medicine
| |
Collapse
|
11
|
He C, Fu P, Zhang K, Xia Q, Yang Y, Xie L. Chinese herbal medicine for dyslipidemia: protocol for a systematic review and meta-analysis. Medicine (Baltimore) 2018; 97:e13048. [PMID: 30383674 PMCID: PMC6221744 DOI: 10.1097/md.0000000000013048] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/05/2018] [Accepted: 10/09/2018] [Indexed: 11/26/2022] Open
Abstract
BACKGROUND Dyslipidemia is commonly characterized by the abnormal quantity and quality of lipids in plasma, which is strongly associated with an increased risk of cardiovascular disease and also a major cause of morbidity and even leads to mortality. In China and East Asia, Chinese herbal medicine has been widely used to treat diverse diseases for thousands of years. As an important means of traditional Chinese medicine treatment, Chinese herbal medicine plays a more important role in the treatment of dyslipidemia. The aim of this study is to assess the efficacy and safety of Chinese herbal medicine for dyslipidemia. METHODS Seven electronic databases (included The Cochrane Library, MEDLINE, Embase, CNKI, VIP, CBM, and WANGFANG) will be searched regardless of publication date or language. Randomized controlled trials will be included if they recruited participants with dyslipidemia for assessing the effect of Chinese herbal medicine vs control (placebo, no treatment, and other therapeutic agents). Primary outcomes will include serum lipid and advent events. Two authors will independently scan the articles searched, extract the data from articles included, and assess the risk of bias by Cochrane tool of risk of bias. Disagreements will be resolved by discussion among authors. All analysis will be performed based on the Cochrane Handbook for Systematic Reviews of Interventions. Dichotomous variables will be reported as risk ratio or odds ratio with 95% confidence intervals (CIs) and continuous variables will be summarized as mean difference or standard mean difference with 95% CIs. RESULTS This review will be to assess the efficacy and safety of Chinese herbal medicine for dyslipidemia. CONCLUSIONS Our findings will assist clinicians and health professionals make clinical decisions regarding dyslipidemia prevention, and promising way for prevention and treatment of patients with dyslipidemia. ETHICS AND DISSEMINATION This study is a protocol for systematic review of Chinese herbal medicine as a treatment of dyslipidemia. This review will be published in a journal and disseminated in print by peer-review. SYSTEMATIC REVIEW REGISTRATION PROSPERO (CRD42018085556).
Collapse
Affiliation(s)
- Caihong He
- First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou
| | - Peng Fu
- First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China
| | - Kexin Zhang
- First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China
| | - Qing Xia
- First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China
| | - Yunmei Yang
- First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou
| | - Liangzhen Xie
- First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China
| |
Collapse
|
12
|
Impact of Changes in Cardiorespiratory Fitness on Hypertension, Dyslipidemia and Survival: An Overview of the Epidemiological Evidence. Prog Cardiovasc Dis 2017; 60:56-66. [DOI: 10.1016/j.pcad.2017.02.006] [Citation(s) in RCA: 40] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/28/2017] [Accepted: 02/28/2017] [Indexed: 02/07/2023]
|
13
|
Reis JP, Auer R, Bancks MP, Goff DC, Lewis CE, Pletcher MJ, Rana JS, Shikany JM, Sidney S. Cumulative Lifetime Marijuana Use and Incident Cardiovascular Disease in Middle Age: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Public Health 2017; 107:601-606. [PMID: 28207342 PMCID: PMC5343712 DOI: 10.2105/ajph.2017.303654] [Citation(s) in RCA: 69] [Impact Index Per Article: 9.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/30/2016] [Indexed: 11/04/2022]
Abstract
OBJECTIVES To investigate the effects of marijuana in the development of incident cardiovascular and cerebrovascular outcomes. METHODS Participants were 5113 adults aged 18 to 30 years at baseline (1985-1986) from the Coronary Artery Risk Development in Young Adults study, who were followed for more than 25 years. We estimated cumulative lifetime exposure to marijuana using repeated assessments collected at examinations every 2 to 5 years. The primary outcome was incident cardiovascular disease (CVD) through 2013. RESULTS A total of 84% (n = 4286) reported a history of marijuana use. During a median 26.9 years (131 990 person-years), we identified 215 CVD events, including 62 strokes or transient ischemic attacks, 104 cases of coronary heart disease, and 50 CVD deaths. Compared with no marijuana use, cumulative lifetime and recent marijuana use showed no association with incident CVD, stroke or transient ischemic attacks, coronary heart disease, or CVD mortality. Marijuana use was not associated with CVD when stratified by age, gender, race, or family history of CVD. CONCLUSIONS Neither cumulative lifetime nor recent use of marijuana is associated with the incidence of CVD in middle age.
Collapse
Affiliation(s)
- Jared P Reis
- Jared P. Reis and David C. Goff Jr are with the Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, MD. Reto Auer is with the Institute of Primary Health Care, University of Bern, Bern, Switzerland. Michael P. Bancks is with the Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL. Cora E. Lewis and James M. Shikany are with the Division of Preventive Medicine, Department of Medicine, University of Alabama, Birmingham. Mark J. Pletcher is with the Department of Epidemiology and Biostatistics, University of California, San Francisco. Jamal S. Rana and Stephen Sidney are with the Division of Research, Kaiser Permanente Northern California, Oakland
| | - Reto Auer
- Jared P. Reis and David C. Goff Jr are with the Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, MD. Reto Auer is with the Institute of Primary Health Care, University of Bern, Bern, Switzerland. Michael P. Bancks is with the Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL. Cora E. Lewis and James M. Shikany are with the Division of Preventive Medicine, Department of Medicine, University of Alabama, Birmingham. Mark J. Pletcher is with the Department of Epidemiology and Biostatistics, University of California, San Francisco. Jamal S. Rana and Stephen Sidney are with the Division of Research, Kaiser Permanente Northern California, Oakland
| | - Michael P Bancks
- Jared P. Reis and David C. Goff Jr are with the Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, MD. Reto Auer is with the Institute of Primary Health Care, University of Bern, Bern, Switzerland. Michael P. Bancks is with the Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL. Cora E. Lewis and James M. Shikany are with the Division of Preventive Medicine, Department of Medicine, University of Alabama, Birmingham. Mark J. Pletcher is with the Department of Epidemiology and Biostatistics, University of California, San Francisco. Jamal S. Rana and Stephen Sidney are with the Division of Research, Kaiser Permanente Northern California, Oakland
| | - David C Goff
- Jared P. Reis and David C. Goff Jr are with the Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, MD. Reto Auer is with the Institute of Primary Health Care, University of Bern, Bern, Switzerland. Michael P. Bancks is with the Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL. Cora E. Lewis and James M. Shikany are with the Division of Preventive Medicine, Department of Medicine, University of Alabama, Birmingham. Mark J. Pletcher is with the Department of Epidemiology and Biostatistics, University of California, San Francisco. Jamal S. Rana and Stephen Sidney are with the Division of Research, Kaiser Permanente Northern California, Oakland
| | - Cora E Lewis
- Jared P. Reis and David C. Goff Jr are with the Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, MD. Reto Auer is with the Institute of Primary Health Care, University of Bern, Bern, Switzerland. Michael P. Bancks is with the Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL. Cora E. Lewis and James M. Shikany are with the Division of Preventive Medicine, Department of Medicine, University of Alabama, Birmingham. Mark J. Pletcher is with the Department of Epidemiology and Biostatistics, University of California, San Francisco. Jamal S. Rana and Stephen Sidney are with the Division of Research, Kaiser Permanente Northern California, Oakland
| | - Mark J Pletcher
- Jared P. Reis and David C. Goff Jr are with the Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, MD. Reto Auer is with the Institute of Primary Health Care, University of Bern, Bern, Switzerland. Michael P. Bancks is with the Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL. Cora E. Lewis and James M. Shikany are with the Division of Preventive Medicine, Department of Medicine, University of Alabama, Birmingham. Mark J. Pletcher is with the Department of Epidemiology and Biostatistics, University of California, San Francisco. Jamal S. Rana and Stephen Sidney are with the Division of Research, Kaiser Permanente Northern California, Oakland
| | - Jamal S Rana
- Jared P. Reis and David C. Goff Jr are with the Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, MD. Reto Auer is with the Institute of Primary Health Care, University of Bern, Bern, Switzerland. Michael P. Bancks is with the Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL. Cora E. Lewis and James M. Shikany are with the Division of Preventive Medicine, Department of Medicine, University of Alabama, Birmingham. Mark J. Pletcher is with the Department of Epidemiology and Biostatistics, University of California, San Francisco. Jamal S. Rana and Stephen Sidney are with the Division of Research, Kaiser Permanente Northern California, Oakland
| | - James M Shikany
- Jared P. Reis and David C. Goff Jr are with the Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, MD. Reto Auer is with the Institute of Primary Health Care, University of Bern, Bern, Switzerland. Michael P. Bancks is with the Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL. Cora E. Lewis and James M. Shikany are with the Division of Preventive Medicine, Department of Medicine, University of Alabama, Birmingham. Mark J. Pletcher is with the Department of Epidemiology and Biostatistics, University of California, San Francisco. Jamal S. Rana and Stephen Sidney are with the Division of Research, Kaiser Permanente Northern California, Oakland
| | - Stephen Sidney
- Jared P. Reis and David C. Goff Jr are with the Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, MD. Reto Auer is with the Institute of Primary Health Care, University of Bern, Bern, Switzerland. Michael P. Bancks is with the Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL. Cora E. Lewis and James M. Shikany are with the Division of Preventive Medicine, Department of Medicine, University of Alabama, Birmingham. Mark J. Pletcher is with the Department of Epidemiology and Biostatistics, University of California, San Francisco. Jamal S. Rana and Stephen Sidney are with the Division of Research, Kaiser Permanente Northern California, Oakland
| |
Collapse
|
14
|
The Impact of Cardiorespiratory Fitness Levels on the Risk of Developing Atherogenic Dyslipidemia. Am J Med 2016; 129:1060-6. [PMID: 27288861 PMCID: PMC5039056 DOI: 10.1016/j.amjmed.2016.05.017] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/28/2016] [Revised: 05/25/2016] [Accepted: 05/25/2016] [Indexed: 02/05/2023]
Abstract
BACKGROUND Low cardiorespiratory fitness has been established as a risk factor for cardiovascular-related morbidity. However, research about the impact of fitness on lipid abnormalities, including atherogenic dyslipidemia, has produced mixed results. The purpose of this investigation is to examine the influence of baseline fitness and changes in fitness on the development of atherogenic dyslipidemia. METHODS All participants completed at least 3 comprehensive medical examinations performed by a physician that included a maximal treadmill test between 1976 and 2006 at the Cooper Clinic in Dallas, Texas. Atherogenic dyslipidemia was defined as a triad of lipid abnormalities: low high-density-lipoprotein cholesterol ([HDL-C] <40 mg/dL), high triglycerides ([TGs] ≥200 mg/dL), and high low-density-lipoprotein cholesterol ([LDL-C] ≥160 mg/dL). RESULTS A total of 193 participants developed atherogenic dyslipidemia during an average of 8.85 years of follow-up. High baseline fitness was protective against the development of atherogenic dyslipidemia in comparison with those with low fitness (odds ratio [OR] 0.57; 95% confidence interval [CI], 0.37-0.89); however, this relationship became nonsignificant after controlling for baseline HDL-C, LDL-C, and TG levels. Participants who maintained fitness over time had lower odds of developing atherogenic dyslipidemia than those with a reduction in fitness (OR 0.56; 95% CI, 0.34-0.91) after adjusting for baseline confounders and changes in known risk factors. CONCLUSIONS High fitness at baseline and maintenance of fitness over time are protective against the development of atherogenic dyslipidemia.
Collapse
|